Boothwyn, PA., Jan. 08, 2026 (GLOBE NEWSWIRE) — Pentec Health, Inc. (Pentec) today announced the acquisition of Hartley Medical Center Pharmacy, LLC (Hartley Medical), a nationally recognized compounding pharmacy focused on the sterile compounding of intrathecal (IT) medications used to treat chronic pain and spasticity. Hartley Medical will continue operating from its Long Beach, California […]

CHICAGO, Jan. 08, 2026 (GLOBE NEWSWIRE) — R1 (“R1” or the “Company”), the leader in healthcare revenue management, today announced the launch of Phare Audit, the most comprehensive AI-native solution for both coding and clinical documentation integrity. It is designed to transform mid-revenue cycle performance by improving accuracy and quality before a bill is generated

(NASDAQ:AMPG),(NASDAQ:AMPGW), HAUPPAUGE, N.Y., Jan. 08, 2026 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), is pleased to announce the appointment of Prof. Tommaso Melodia to its Board of Advisors, effective immediately. Professor Tommaso Melodia brings over two decades of leadership in wireless communications, next-generation network architectures, and artificial intelligence applied to wireless systems. He

NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — G Squared, a leading global venture capital firm specializing in private secondary markets, and Nasdaq Private Market (NPM), a leading provider of liquidity programs and investment opportunities for private companies, employee shareholders, and investors, today announced a strategic alliance to facilitate and fund company-driven secondary liquidity events.

(NASDAQ:RVPH), Findings reinforce brilaroxazine's treatment effect on negative symptoms and other symptom domains in schizophrenia and support clinician-assessed efficacy outcomes in a Phase 3 trial of brilaroxazine Findings also support use of speech latency as an enrichment tool that can reduce sample-size and enhance outcomes in clinical trials for schizophrenia CUPERTINO, Calif., Jan. 08, 2026

MIAMI, Jan. 08, 2026 (GLOBE NEWSWIRE) — RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today provided a corporate update and announced its strategic priorities for 2026. “We had a remarkable 2025, where we made significant progress across our pipeline of advanced cell therapeutics. In

(NASDAQ:GRI), New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung repair, and improved lung function LA JOLLA, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) — GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of immune cell modulators for the treatment of inflammatory,

(NasdaqGM:SITM), SANTA CLARA, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) — SiTime Corporation (Nasdaq: SITM), the Precision Timing company, today announced that SiTime's chief executive officer, Rajesh Vashist, will participate at the 28th Annual Needham Growth Conference to be held at the Lotte New York Palace Hotel. SiTime management is scheduled to host a fireside chat

(TSX-V:ZAC),(Pinksheets:ZCTSF),(PinkSheets:ZCTSF),(Boerse Frankfurt – Freiverkehr:7TV),(Boerse Frankfurt – Freiverkehr:7TV.F), VANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) — Zacatecas Silver Corp. (TSXV: ZAC | OTCQB: ZCTSF | FRA: 7TV) (“Zacatecas Silver” or the “Company”) is pleased to provide shareholders with a corporate update outlining key operational progress across its portfolio and highlighting recent regulatory developments in Mexico

(NYSE:CRC), LONG BEACH, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) — California Resources Corporation (NYSE: CRC) and the Los Angeles Rams today celebrated the first year of their “Football Without the Footprint” partnership, an innovative carbon management initiative designed to reduce and offset the team's carbon emissions. The partnership demonstrates a tangible path toward decarbonization while